GILEAD SCIENCES, INC. Non-operating Income/Expense 2007-2026 | GILD
Beta
What is GILEAD SCIENCES, INC.'s current non-operating income/expense?
GILEAD SCIENCES, INC. (GILD) annual non-operating income/expense for 2025 was $798.0M, a 13200.00% increase from 2024. GILEAD SCIENCES, INC. non-operating income/expense for the quarter ending March 31, 2026 was $235.0M.
What was GILEAD SCIENCES, INC.'s non-operating income/expense in 2024?
GILEAD SCIENCES, INC. annual non-operating income/expense for 2024 was $6.0M, a 96.97% decline from 2023.
What was GILEAD SCIENCES, INC.'s non-operating income/expense in 2023?
GILEAD SCIENCES, INC. annual non-operating income/expense for 2023 was $198.0M, a 134.08% increase from 2022.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-1.42B
→
FY2025
$798.0M
07080910111213141516171819202122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $798.0M | +13200.0% | 10-K |
| FY2024 | $6.0M | -97.0% | 10-K |
| FY2023 | $198.0M | +134.1% | 10-K |
| FY2022 | $-581.0M | +9.1% | 10-K |
| FY2021 | $-639.0M | +54.9% | 10-K |
| FY2020 | $-1.42B | -175.9% | 10-K |
| FY2019 | $1.87B | +176.3% | 10-K |
| FY2018 | $676.0M | +29.3% | 10-K |
| FY2017 | $523.0M | +22.2% | 10-K |
| FY2016 | $428.0M | +177.9% | 10-K |
| FY2015 | $154.0M | +5033.3% | 10-K |
| FY2014 | $3.0M | +133.3% | 10-K |
| FY2013 | $-9.0M | +75.7% | 10-K |
| FY2012 | $-37.0M | -155.6% | 10-K |
| FY2011 | $66.6M | +10.4% | 10-K |
| FY2010 | $60.3M | +42.2% | 10-K |
| FY2009 | $42.4M | -28.6% | 10-K |
| FY2008 | $59.4M | -45.9% | 10-K |
| FY2007 | $109.8M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →